[HTML][HTML] Psychotropics and the microbiome: a chamber of secrets…
The human gut contains trillions of symbiotic bacteria that play a key role in programming
different aspects of host physiology in health and disease. Psychotropic medications act on …
different aspects of host physiology in health and disease. Psychotropic medications act on …
Recent advancements in mechanistic studies and structure activity relationship of FoF1 ATP synthase inhibitor as antimicrobial agent
The emergence of drug resistance in infectious microbial strains can be overcome by
development of novel drug molecules against unexploited microbial target. The success of …
development of novel drug molecules against unexploited microbial target. The success of …
[HTML][HTML] Dos distúrbios psiquiátricos à antibioticoterapia: reposicionamento da clorpromazina como agente antibacteriano
WG Lima, MC Ramos-Alves, AC Soares - Revista Colombiana de …, 2019 - scielo.org.co
RESUMO O alarmante aumento na taxa de resistência aos antibióticos põe em check à
eficácia da terapia antibacteriana futura. Em contrapartida, as indústrias farmacêuticas …
eficácia da terapia antibacteriana futura. Em contrapartida, as indústrias farmacêuticas …
Efflux Pump Inhibitors, Alpha-Tocopherol and Aspirin: Role in Campylobacter jejuni and Campylobacter coli Fluoroquinolone Resistance
This study aimed to investigate how efflux pump activity contributes to high fluoroquinolone
(FQ) resistance in Campylobacter jejuni and Campylobacter coli isolates and to evaluate the …
(FQ) resistance in Campylobacter jejuni and Campylobacter coli isolates and to evaluate the …
Effect of various drugs on differentially detectable persisters of Mycobacterium tuberculosis generated by long-term lipid diet
SR Khan, U Venugopal, G Chandra, S Bharti… - Tuberculosis, 2019 - Elsevier
Abstract Persisters of Mycobacterium tuberculosis (Mtb) that fail to form colonies on agar
media when de-stressed are termed as differentially d etectable (DD) persisters. Since in the …
media when de-stressed are termed as differentially d etectable (DD) persisters. Since in the …
From psychiatric disorders to antibiotic therapy: repositioning of chlorpromazine as an antibacterial agent
WG Lima, MC Ramos-Alves, AC Soares - Revista Colombiana de …, 2019 - scielo.org.co
Abstract LIMA, William Gustavo; RAMOS-ALVES, Maria Cristina and SOARES, Adriana
Cristina. From psychiatric disorders to antibiotic therapy: repositioning of chlorpromazine as …
Cristina. From psychiatric disorders to antibiotic therapy: repositioning of chlorpromazine as …
In vitro and in vivo toxicity evaluation of non-neuroleptic phenothiazines, antitubercular drug candidates
S Salie, A Labuschagné, A Walters, S Geyer… - Regulatory Toxicology …, 2019 - Elsevier
The phenothiazine-derived antipsychotic drugs, such as chlorpromazine and thioridazine,
are bactericidal against drug-sensitive and drug-resistant strains of Mycobacterium …
are bactericidal against drug-sensitive and drug-resistant strains of Mycobacterium …
Clinical management of drug-resistant Mycobacterium tuberculosis strains: pathogen-targeted versus host-directed treatment approaches
H Al-Ghafli, S Al-Hajoj - Current Pharmaceutical Biotechnology, 2019 - ingentaconnect.com
Background: Despite exerted efforts to control and treat Mycobacterium tuberculosis (MTB)
strains, Tuberculosis (TB) remains a public health menace. The emergence of complex drug …
strains, Tuberculosis (TB) remains a public health menace. The emergence of complex drug …
Antibacterial properties of thioridazine
N Hrynchuk, N Vrynchanu - Farmatsevtychnyi zhurnal, 2019 - pharmj.org.ua
УДК 615.214.21:579.8 DOI: 10.32352/0367-3057.4.19.11 НІГРИНЧУК (https://orcid.org/0000-0002-2069-5917),
Н. Page 1 96 ISSN 0367-3057, Фармацевтичний журнал, 2019, № 4 © НІГринчук, НОВринчану …
Н. Page 1 96 ISSN 0367-3057, Фармацевтичний журнал, 2019, № 4 © НІГринчук, НОВринчану …
Recent Advances in Repositioning Non-Antibiotics against Tuberculosis and other Neglected Tropical Diseases
MMD Semenya - Medicinal Chemistry of Neglected and Tropical …, 2019 - taylorfrancis.com
Multiple tuberculosis (TB) drug development campaigns capitalize on drugs already
approved by regulatory authorities including those originally indicated for diseases of a non …
approved by regulatory authorities including those originally indicated for diseases of a non …